Sign in
Taking people in United StatesNo phase

Collects health data and samples from people with plasma cell disorders

Gathers health information and samples from adults with plasma cell disorders for future research.

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the site
Trial code
Registry title
The Indiana Myeloma Registry
Status
Recruiting
People taking part
2,500 people, planned
Started
18 Jun 2018
Expected to end
30 Jun 2028
Type of study
Observational
Treatments tested
  • This is a non-interventional trial
Record updated
29 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have, or may have, MGUS, smoldering multiple myeloma, multiple myeloma, a plasmacytoma or primary amyloidosis. It collects data and samples for future research.

Age
18 years or older
Sex
Men and women can join.
Disease stage
Diagnosed with or suspected to have one of these: MGUS, smoldering multiple myeloma, multiple myeloma, bony or soft tissue plasmacytoma, primary amyloidosis.

Main reasons for not taking part

  • Younger than 18 years
  • Not diagnosed with any of the listed conditions

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Male or female patients ≥ 18 years of age at the time of informed consent
  • Has been diagnosed with or is suspected to have one of the following:; Monoclonal Gammopathy of Undetermined Significance (MGUS); Smoldering Multiple Myeloma; Multiple Myeloma; Bony or Soft Tissue Plasmacytoma; Primary Amyloidosis

Who cannot take part

  • < 18 years of age
  • Have not been diagnosed with one of the following:
  • Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Where in United States

  • Indiana University Simon Cancer CenterIndianapolis, United StatesContact: Attaya Suvannasankha, MDTaking people

About the trial

What the trial wants to find out

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Treatments tested

  • This is a non-interventional trial

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry
Plain-language title
Collects health data and samples from people with plasma cell disordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
29 October 2026